# Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus

> **NCT05056935** · PHASE2 · COMPLETED · sponsor: **Newsoara Biopharma Co., Ltd.** · enrollment: 131 (actual)

## Conditions studied

- Ileus

## Interventions

- **DRUG:** LB1148
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05056935
- **Lead sponsor:** Newsoara Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-09
- **Primary completion:** 2020-07-22
- **Final completion:** 2020-08-08
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2021-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05056935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05056935, "Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05056935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*